Beckman coulter's dxi 9000 immunoassay analyzer with increased assay development sensitivity makes first north american appearance at 2023 aacc

Anaheim, calif. , july 25, 2023 /prnewswire/ -- beckman coulter, a clinical diagnostics leader, today revealed for the first time in north america the dxi 9000 access immunoassay analyzer, addressing clinical laboratory demands for speed, reliability, reproducibility, quality, and menu expansion.
DHR Ratings Summary
DHR Quant Ranking